Literature DB >> 31019304

Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport.

Jonathan A Coleman1, Dongxue Yang1, Zhiyu Zhao2, Po-Chao Wen2, Craig Yoshioka3, Emad Tajkhorshid2, Eric Gouaux4,5.   

Abstract

The serotonin transporter (SERT) regulates neurotransmitter homeostasis through the sodium- and chloride-dependent recycling of serotonin into presynaptic neurons1-3. Major depression and anxiety disorders are treated using selective serotonin reuptake inhibitors-small molecules that competitively block substrate binding and thereby prolong neurotransmitter action2,4. The dopamine and noradrenaline transporters, together with SERT, are members of the neurotransmitter sodium symporter (NSS) family. The transport activities of NSSs can be inhibited or modulated by cocaine and amphetamines2,3, and genetic variants of NSSs are associated with several neuropsychiatric disorders including attention deficit hyperactivity disorder, autism and bipolar disorder2,5. Studies of bacterial NSS homologues-including LeuT-have shown how their transmembrane helices (TMs) undergo conformational changes during the transport cycle, exposing a central binding site to either side of the membrane1,6-12. However, the conformational changes associated with transport in NSSs remain unknown. To elucidate structure-based mechanisms for transport in SERT we investigated its complexes with ibogaine, a hallucinogenic natural product with psychoactive and anti-addictive properties13,14. Notably, ibogaine is a non-competitive inhibitor of transport but displays competitive binding towards selective serotonin reuptake inhibitors15,16. Here we report cryo-electron microscopy structures of SERT-ibogaine complexes captured in outward-open, occluded and inward-open conformations. Ibogaine binds to the central binding site, and closure of the extracellular gate largely involves movements of TMs 1b and 6a. Opening of the intracellular gate involves a hinge-like movement of TM1a and the partial unwinding of TM5, which together create a permeation pathway that enables substrate and ion diffusion to the cytoplasm. These structures define the structural rearrangements that occur from the outward-open to inward-open conformations, and provide insight into the mechanism of neurotransmitter transport and ibogaine inhibition.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31019304      PMCID: PMC6750207          DOI: 10.1038/s41586-019-1135-1

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  1 in total

1.  CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields.

Authors:  K Vanommeslaeghe; E Hatcher; C Acharya; S Kundu; S Zhong; J Shim; E Darian; O Guvench; P Lopes; I Vorobyov; A D Mackerell
Journal:  J Comput Chem       Date:  2010-03       Impact factor: 3.376

  1 in total
  58 in total

1.  A Novel Bromine-Containing Paroxetine Analogue Provides Mechanistic Clues for Binding Ambiguity at the Central Primary Binding Site of the Serotonin Transporter.

Authors:  Rachel D Slack; Ara M Abramyan; Helen Tang; Sitaram Meena; Bruce A Davis; Alessandro Bonifazi; JoLynn B Giancola; Jeffrey R Deschamps; Sett Naing; Hideaki Yano; Satinder K Singh; Amy Hauck Newman; Lei Shi
Journal:  ACS Chem Neurosci       Date:  2019-08-22       Impact factor: 4.418

2.  Serotonin transporter protein in autopsied brain of chronic users of cocaine.

Authors:  Junchao Tong; Jeffrey H Meyer; Isabelle Boileau; Lee-Cyn Ang; Paul J Fletcher; Yoshiaki Furukawa; Stephen J Kish
Journal:  Psychopharmacology (Berl)       Date:  2020-06-03       Impact factor: 4.530

Review 3.  Ligand binding at the protein-lipid interface: strategic considerations for drug design.

Authors:  Jian Payandeh; Matthew Volgraf
Journal:  Nat Rev Drug Discov       Date:  2021-07-13       Impact factor: 84.694

4.  A Global Ramachandran Score Identifies Protein Structures with Unlikely Stereochemistry.

Authors:  Oleg V Sobolev; Pavel V Afonine; Nigel W Moriarty; Maarten L Hekkelman; Robbie P Joosten; Anastassis Perrakis; Paul D Adams
Journal:  Structure       Date:  2020-08-27       Impact factor: 5.006

5.  Chemical and structural investigation of the paroxetine-human serotonin transporter complex.

Authors:  Jonathan A Coleman; Vikas Navratna; Daniele Antermite; Dongxue Yang; James A Bull; Eric Gouaux
Journal:  Elife       Date:  2020-07-03       Impact factor: 8.140

Review 6.  Monoamine transporters: structure, intrinsic dynamics and allosteric regulation.

Authors:  Mary Hongying Cheng; Ivet Bahar
Journal:  Nat Struct Mol Biol       Date:  2019-07-03       Impact factor: 15.369

Review 7.  A guide to plasma membrane solute carrier proteins.

Authors:  Mattia D Pizzagalli; Ariel Bensimon; Giulio Superti-Furga
Journal:  FEBS J       Date:  2020-09-18       Impact factor: 5.542

8.  An Interfacial Sodium Ion is an Essential Structural Feature of Fluc Family Fluoride Channels.

Authors:  Benjamin C McIlwain; Kamirah Martin; Elizabeth A Hayter; Randy B Stockbridge
Journal:  J Mol Biol       Date:  2020-01-14       Impact factor: 5.469

9.  GemSpot: A Pipeline for Robust Modeling of Ligands into Cryo-EM Maps.

Authors:  Michael J Robertson; Gydo C P van Zundert; Kenneth Borrelli; Georgios Skiniotis
Journal:  Structure       Date:  2020-05-14       Impact factor: 5.006

10.  The Structure and Mechanism of Drug Transporters.

Authors:  Arthur G Roberts
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.